A U.S. bankruptcy court judge rejected Johnson & Johnson's $9 billion settlement plan for talc-related cancer claims, marking the third bankruptcy case for a J&J subsidiary. The company will now return to litigate talc claims in civil court.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay